Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2008-05-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm701444yPMID 18410084PMCID PMC2782568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of synthetic peptides by capillary zone electrophoresis in organic/aqueous buffers.

  2009influential reference
• Astressin-amide and astressin-acid are structurally different in dimethylsulfoxide.

  2007cited by this paper
• Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand

  2007cited by this paper
• Novel insights in somatostatin receptor physiology.

  2007influential reference
• Norcystine, a new tool for the study of the structure-activity relationship of peptides.

  2006cited by this paper
• Conformational analysis of a potent SSTR3‐selective somatostatin analogue by NMR in water solution

  2006cited by this paper
• Efficacy and limits of somatostatin analogs.

  2005cited by this paper
• Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.

  2005influential reference
• Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.

  2005cited by this paper
• The puzzle of somatostatin: action, receptors, analogues and therapy.

  2005cited by this paper
• Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.

  2005cited by this paper
• Novel subtype specific and universal somatostatin analogues: clinical potential and pitfalls.

  2005cited by this paper
• Candidates for peptide receptor radiotherapy today and in the future.

  2005cited by this paper
• Receptor-Mediated Tumor Targeting with Radiopeptides. Part 1. General Concepts and Methods: Applications to Somatostatin Receptor-Expressing Tumors

  2004cited by this paper
• NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor.

  2004cited by this paper
• Regulation and function of somatostatin receptors

  2004influential reference
• Somatostatin receptors.

  2003cited by this paper
• Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.

  2003cited by this paper
• Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.

  2003cited by this paper
• Opportunities in somatostatin research: biological, chemical and therapeutic aspects

  2003influential reference
• A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.

  2003influential reference
• Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.

  2003cited by this paper
• Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.

  2003cited by this paper
• Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.

  2003cited by this paper
• Peptide receptors as molecular targets for cancer diagnosis and therapy.

  2003influential reference
• New somatostatin analogs: will they fulfil old promises?

  2002influential reference
• Erratum to: Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

  2001influential reference
• Somatostatin analogs.

  2001cited by this paper
• Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

  2001cited by this paper
• Hypothalamic hormones and cancer.

  2001influential reference
• Cellular biology of somatostatin receptors.

  2001influential reference
• Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).

  2001influential reference
• Consensus bioactive conformation of cyclic GnRH antagonists defined by NMR and molecular modeling.

  2000cited by this paper
• Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

  2000cited by this paper
• Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location.

  2000influential reference
• SST3-selective potent peptidic somatostatin receptor antagonists.

  2000cited by this paper
• Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin.

  1999cited by this paper
• A selective analog for the somatostatin sst1-receptor subtype expressed by human tumors.

  1998cited by this paper
• A refined model for the somatostatin pharmacophore: conformational analysis of lanthionine-sandostatin analogs.

  1997cited by this paper
• Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.

  1997cited by this paper
• Multiconformational NMR analysis of sandostatin (octreotide): equilibrium between beta-sheet and partially helical structures.

  1997cited by this paper
• Torsion angle dynamics for NMR structure calculation with the new program DYANA.

  1997cited by this paper
• MOLMOL: a program for display and analysis of macromolecular structures.

  1996cited by this paper
• Identification of Ligand Binding Determinants in the Somatostatin Receptor Subtypes 1 and 2*

  1996cited by this paper
• Peptide chemistry: development of high performance liquid chromatography and capillary zone electrophoresis.

  1996influential reference
• Molecular biology of somatostatin receptors.

  1995influential reference
• NMR of proteins and nucleic acids

  1988cited by this paper
• Dynamics and conformational energetics of a peptide hormone: vasopressin.

  1985cited by this paper
• SYNTHESIS OF THE MERRIFIELD RESIN ESTERS OF N-PROTECTED AMINO ACIDS WITH THE AID OF HYDROGEN BONDING1

  1978cited by this paper
• Biologic and immunologic activities and applications of somatostatin analogs.

  1978cited by this paper
• Pharmacology of thyrotropin releasing factor (TRF), luteinizing hormone releasing factor (LRF), and somatostatin.

  1977cited by this paper
• Somatostatin: physiological and clinical significance.

  1976influential reference
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

  1973influential reference
• THIOETHER DERIVATIVES OF CYSTEINE AND HOMOCYSTEINE1

  1951cited by this paper
• Growth experiments with thioether derivatives of cysteine and homocysteine.

  1951cited by this paper

• Toward tryptathionine-stapled one-bead-one-compound (OBOC) libraries: solid phase synthesis of a bioactive octretoate analog.

  2023cites this paper
• Central somatostatin signaling and regulation of food intake

  2019cites this paper
• Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response

  2017cites this paper
• Synthesis on the solid phase of a bioactive tryptathionine octreotate

  2017cites this paper
• Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.

  2015cites this paper
• The role of brain somatostatin receptor 2 in the regulation of feeding and drinking behavior.

  2015cites this paper
• Central Control of Fluid and Electrolyte Homeostasis Brain somatostatin receptor 2 mediates the dipsogenic effect of central somatostatin and cortistatin in rats: role in drinking behavior

  2014cites this paper
• Radionuclides for Imaging and Therapy in Oncology

  2014cites this paper
• Pharmacological properties of novel cyclic pentapeptides with µ-opioid receptor agonist activity.

  2014cites this paper
• Prospective of 68 Ga-Radiopharmaceutical Development

  2014cites this paper
• Orexigenic response to tail pinch: role of brain NPY(1) and corticotropin releasing factor receptors.

  2014cites this paper
• [DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting.

  2014cites this paper
• Orexin-1 receptor mediates the increased food and water intake induced by intracerebroventricular injection of the stable somatostatin pan-agonist, ODT8-SST in rats

  2014cites this paper
• Prospective of 68Ga-Radiopharmaceutical Development

  2013cites this paper
• The diversity of (68)Ga-based imaging agents.

  2013cites this paper
• Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications

  2013influential citation
• Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

  2013cites this paper
• Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes.

  2012cites this paper
• Cyclic peptides with a diversely substituted guanidine bridge: solid-phase synthesis and structural analysis.

  2011cites this paper
• Chronic injection of pansomatostatin agonist ODT8-SST differentially modulates food intake and decreases body weight gain in lean and diet-induced obese rats.

  2011influential citation
• Positron emitting [68Ga]Ga-based imaging agents: chemistry and diversity.

  2011cites this paper
• Central somatostatin receptor 1 activation reverses acute stress‐related alterations of gastric and colonic motor function in mice

  2011cites this paper
• Central administration of pan‐somatostatin agonist ODT8‐SST prevents abdominal surgery‐induced inhibition of circulating ghrelin, food intake and gastric emptying in rats

  2011cites this paper
• SSTR1‐ and SSTR3‐Selective Somatostatin Analogues

  2011cites this paper
• Pattern of Fos expression in the brain induced by selective activation of somatostatin receptor 2 in rats.

  2010cites this paper
• Activation of brain somatostatin 2 receptors stimulates feeding in mice: analysis of food intake microstructure.

  2010cites this paper
• Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats.

  2010cites this paper
• Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity.

  2008cites this paper
• Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR.

  2008cites this paper